financetom
Business
financetom
/
Business
/
Trump SPAC Merger Approved, Set For Imminent Public Debut: The Profits Some Investors Missed
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump SPAC Merger Approved, Set For Imminent Public Debut: The Profits Some Investors Missed
Mar 25, 2024 8:43 AM

A highly anticipated SPAC merger between Digital World Acquisition Corporation ( DWAC ) and Trump Media & Technology Group was approved Friday.

Here's how some investors missed out on thousands of dollars from the merger process.

What Happened: First announced in October 2021, a merger between Digital World Acquisition Corporation ( DWAC ) and Trump Media & Technology Group has faced several setbacks and delays.

Friday’s merger approval saw the majority of shareholders voting to push the deal forward. The merger will bring a media company founded and majority owned by former President Donald Trump public.

"We are immensely grateful to our stockholders and our working group for their continued trust and support. This vote underscores their confidence in the merger with TMTG and the path we have set for the future," Digital World CEO Eric Swider said.

As part of the SPAC merger process, shareholders are able to redeem their shares at net asset value at the time of the merger vote. This can happen during votes to extend deadlines or upon approval.

According to SPAC expert Julian Klymochko, a total of 4,939 shares of Digital World Acquisition Corporation ( DWAC ) were redeemed at the merger vote.

These shares were cashed out at net asset value, which is listed at $10.85.

Instead of redeeming the shares at net asset value, the shareholders could have sold shares at around $37 on Friday during regular market hours.

This means that any shareholders who redeemed shares missed out on a potential price that was 71% higher.

In total, the shareholders who redeemed missed out in $129,154.85 based on the redemption price and $37 market price on Friday.

Related Link: Trump To Maintain Control Of Media Company If He Sells Majority, Goes To Jail Or Becomes President

What's Next: The newly created company is expected to make its market debut this week. The company will trade as Trump Media & Technology Group with the ticker DJT on the Nasdaq. The symbol is in reference to Donald J. Trump, the former president and principal owner of the media company that operates the Truth Social platform, with ambitions for additional growth through video and media offerings.

"As we transition into a public company, we look forward to greatly enhancing and expanding Truth Social and providing Americans with an enduring safe harbor from Big Tech's stifling censorship and suppression," Trump Media & Technology Group CEO Devin Nunes said.

Trump will own 80 million shares in the newly formed company and faces lock-ups that could be changed by the company's board of directors. Trump is also subject to unlocking additional shares based on milestones for the stock in the coming months.

DWAC Price Action: Shares of Digital World Acquisition ( DWAC ) were 9.3% to $40.40 at the time of publication on Monday. With the merger finalization and ticker symbol change, coupled with various Trump-associated events, the stock is expected to experience significant volatility throughout the week.

Read Next: Trump Tried To Get Elon Musk To Buy Truth Social: New Report Highlights Former President’s Pitch

Image generated using artificial intelligence with Midjourney.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims
Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims
Oct 2, 2024
WASHINGTON (Reuters) -Shares of Cassava Sciences fell 10% in post-market trading on Thursday after the U.S. Securities and Exchange Commission charged the biopharmaceutical company and two former executives for misleading claims about the results of Alzheimer's clinical trials. The misleading statements were made in September 2020 about the results of a phase two clinical trial for Cassava's purported drug treatment...
Ovintiv Renews Buyback Program for 10% of Outstanding Shares
Ovintiv Renews Buyback Program for 10% of Outstanding Shares
Oct 2, 2024
05:44 PM EDT, 09/26/2024 (MT Newswires) -- Ovintiv ( OVV ) disclosed regulatory approvals late Thursday to renew its share buyback program to repurchase 10% of its public float as of Sept. 20. The program, which returns at least 50% of non-GAAP free cash flow to shareholders after base dividend, said the Toronto Stock Exchange accepted the renewal of its...
US FDA approves Bristol Myers' schizophrenia drug
US FDA approves Bristol Myers' schizophrenia drug
Oct 2, 2024
(Corrects paragraph 1 to say U.S. FDA is news source, not Bristol Myers) Sept 26 (Reuters) - The U.S. FDA approved Bristol Myers Squibb's ( BMY ) schizophrenia drug on Thursday, providing patients with a treatment option that reduces symptoms of the mental disorder without common side effects, the health regulator said. ...
Mosaic Expected Q3 Sales Disruptions Due to Equipment Problems, Hurricanes
Mosaic Expected Q3 Sales Disruptions Due to Equipment Problems, Hurricanes
Oct 2, 2024
06:04 PM EDT, 09/26/2024 (MT Newswires) -- Mosaic (MOS) late Thursday said Q3 sales volumes of potash and phosphates would likely trail its prior forecasts due to production disruptions and other operational challenges at several facilities. The company is now expecting potash sales between 1.85 million to 2.05 million tonnes during Q3, down from its earlier guidance looking for 2.1...
Copyright 2023-2026 - www.financetom.com All Rights Reserved